SARA COBURN: Open Payments
NPI 1861115750 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,519 in 199 payments from 16 companies in 2025. Trend: 2023 $2,240 · 2024 $3,211 · 2025 $3,519
Food & beverage: $3,407Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $602 |
| E.R. Squibb & Sons, L.L.C. | 35 | $567 |
| Teva Pharmaceuticals USA, Inc. | 14 | $431 |
| Lundbeck LLC | 24 | $387 |
| Otsuka America Pharmaceutical, Inc. | 15 | $356 |
| Alkermes, Inc. | 14 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $249 |
| Neurocrine BioSciences, Inc. | 10 | $167 |
| Supernus Pharmaceuticals, Inc. | 5 | $105 |
| Corium, LLC | 6 | $102 |
Products named: VRAYLAR, REXULTI, COBENFY, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, INGREZZA, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
